CST
Charles Schwab Trust’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Sell |
16,603
-2,352
| -12% | -$437K | 0.23% | 53 |
|
|
2025
Q1 | $3.97M | Sell |
18,955
-2,648
| -12% | -$555K | 0.33% | 43 |
|
|
2024
Q4 | $3.84M | Buy |
21,603
+288
| +1% | +$51.2K | 0.33% | 42 |
|
|
2024
Q3 | $4.21M | Sell |
21,315
-100
| -0.5% | -$19.7K | 0.36% | 41 |
|
|
2024
Q2 | $3.67M | Buy |
21,415
+830
| +4% | +$142K | 0.34% | 42 |
|
|
2024
Q1 | $3.75M | Sell |
20,585
-4,511
| -18% | -$821K | 0.35% | 40 |
|
|
2023
Q4 | $3.89M | Buy |
25,096
+904
| +4% | +$140K | 0.38% | 43 |
|
|
2023
Q3 | $3.61M | Buy |
24,192
+4,821
| +25% | +$719K | 0.41% | 43 |
|
|
2023
Q2 | $2.67M | Sell |
19,371
-304
| -2% | -$41.9K | 0.32% | 42 |
|
|
2023
Q1 | $3.14M | Buy |
19,675
+1,556
| +9% | +$248K | 0.38% | 40 |
|
|
2022
Q4 | $2.93M | Buy |
18,119
+2,667
| +17% | +$431K | 0.39% | 44 |
|
|
2022
Q3 | $2.07M | Buy |
15,452
+254
| +2% | +$34.1K | 0.35% | 48 |
|
|
2022
Q2 | $2.33M | Sell |
15,198
-170
| -1% | -$26K | 0.48% | 33 |
|
|
2022
Q1 | $2.49M | Buy |
15,368
+596
| +4% | +$96.6K | 0.44% | 35 |
|
|
2021
Q4 | $2M | Sell |
14,772
-25
| -0.2% | -$3.39K | 0.32% | 44 |
|
|
2021
Q3 | $1.6M | Buy |
14,797
+146
| +1% | +$15.7K | 0.31% | 58 |
|
|
2021
Q2 | $1.65M | Sell |
14,651
-228
| -2% | -$25.7K | 0.32% | 59 |
|
|
2021
Q1 | $1.62M | Buy |
14,879
+209
| +1% | +$22.7K | 0.33% | 56 |
|
|
2020
Q4 | $1.57M | Hold |
14,670
| – | – | 0.38% | 60 |
|
|
2020
Q3 | $1.29M | Buy |
14,670
+230
| +2% | +$20.1K | 0.39% | 56 |
|
|
2020
Q2 | $1.42M | Buy |
14,440
+6,688
| +86% | +$657K | 0.47% | 51 |
|
|
2020
Q1 | $591K | Buy |
7,752
+2,325
| +43% | +$177K | 0.24% | 85 |
|
|
2019
Q4 | $481K | Hold |
5,427
| – | – | 0.19% | 107 |
|
|
2019
Q3 | $397K | Buy |
+5,427
| New | +$397K | 0.19% | 97 |
|